KAYA, B. Et Al. 2022. New thiosemicarbazone-based Zinc(II) complexes. In vitro cytotoxicity competing with cisplatin on malignant melanoma A375 cells and its relation to neuraminidase inhibition. Chemico-Biological Interactions , vol.351 .

KAYA, B., Kalındemirtaş, F., Ertik, O., YANARDAĞ, R., Kuruca, S. E., & ÜLKÜSEVEN, B., (2022). New thiosemicarbazone-based Zinc(II) complexes. In vitro cytotoxicity competing with cisplatin on malignant melanoma A375 cells and its relation to neuraminidase inhibition. Chemico-Biological Interactions , vol.351.

KAYA, BUŞRA Et Al. "New thiosemicarbazone-based Zinc(II) complexes. In vitro cytotoxicity competing with cisplatin on malignant melanoma A375 cells and its relation to neuraminidase inhibition," Chemico-Biological Interactions , vol.351, 2022

KAYA, BUŞRA Et Al. "New thiosemicarbazone-based Zinc(II) complexes. In vitro cytotoxicity competing with cisplatin on malignant melanoma A375 cells and its relation to neuraminidase inhibition." Chemico-Biological Interactions , vol.351, 2022

KAYA, B. Et Al. (2022) . "New thiosemicarbazone-based Zinc(II) complexes. In vitro cytotoxicity competing with cisplatin on malignant melanoma A375 cells and its relation to neuraminidase inhibition." Chemico-Biological Interactions , vol.351.

@article{article, author={BUŞRA KAYA Et Al. }, title={New thiosemicarbazone-based Zinc(II) complexes. In vitro cytotoxicity competing with cisplatin on malignant melanoma A375 cells and its relation to neuraminidase inhibition}, journal={Chemico-Biological Interactions}, year=2022}